Fennec Pharmaceuticals Inc. The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased Fennec Pharmaceuticals Inc. (NASDAQ: FENC) securities between February 11, 2020 and August 10, 2020.
According to the Fennec lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the manufacturing facilities for PEDMARK, the Company’s sole product candidate, did not comply with current good manufacturing practices; (2) as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
“Fennec Pharmaceuticals Inc.”
If you suffered a loss in Fennec you have until November 2, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.